These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. BMP and Activin Membrane Bound Inhibitor Regulates the Extracellular Matrix in the Trabecular Meshwork. Hernandez H; Millar JC; Curry SM; Clark AF; McDowell CM Invest Ophthalmol Vis Sci; 2018 Apr; 59(5):2154-2166. PubMed ID: 29801150 [TBL] [Abstract][Full Text] [Related]
9. A Novel Mouse Model of TGFβ2-Induced Ocular Hypertension Using Lentiviral Gene Delivery. Patil SV; Kasetti RB; Millar JC; Zode GS Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35805889 [TBL] [Abstract][Full Text] [Related]
10. TGFbeta2-induced changes in human trabecular meshwork: implications for intraocular pressure. Fleenor DL; Shepard AR; Hellberg PE; Jacobson N; Pang IH; Clark AF Invest Ophthalmol Vis Sci; 2006 Jan; 47(1):226-34. PubMed ID: 16384967 [TBL] [Abstract][Full Text] [Related]
11. Cellular fibronectin expression in human trabecular meshwork and induction by transforming growth factor-β2. Medina-Ortiz WE; Belmares R; Neubauer S; Wordinger RJ; Clark AF Invest Ophthalmol Vis Sci; 2013 Oct; 54(10):6779-88. PubMed ID: 24030464 [TBL] [Abstract][Full Text] [Related]
12. The application of lentiviral vectors for the establishment of TGFβ2-induced ocular hypertension in C57BL/6J mice. Peng M; Margetts TJ; Rayana NP; Sugali CK; Dai J; Mao W Exp Eye Res; 2022 Aug; 221():109137. PubMed ID: 35691374 [TBL] [Abstract][Full Text] [Related]
13. Astragaloside IV Attenuates Ocular Hypertension in a Mouse Model of TGFβ2 Induced Primary Open Angle Glaucoma. Kasetti RB; Maddineni P; Kodati B; Nagarajan B; Yacoub S Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830390 [TBL] [Abstract][Full Text] [Related]
14. Transforming growth factor β2 (TGFβ2) signaling plays a key role in glucocorticoid-induced ocular hypertension. Kasetti RB; Maddineni P; Patel PD; Searby C; Sheffield VC; Zode GS J Biol Chem; 2018 Jun; 293(25):9854-9868. PubMed ID: 29743238 [TBL] [Abstract][Full Text] [Related]
15. Using CRISPR Interference as a Therapeutic Approach to Treat TGFβ2-Induced Ocular Hypertension and Glaucoma. Rayana NP; Sugali CK; Dai J; Peng M; Liu S; Zhang Y; Wan J; Mao W Invest Ophthalmol Vis Sci; 2021 Sep; 62(12):7. PubMed ID: 34499703 [TBL] [Abstract][Full Text] [Related]
16. Smad3 is necessary for transforming growth factor-beta2 induced ocular hypertension in mice. McDowell CM; Tebow HE; Wordinger RJ; Clark AF Exp Eye Res; 2013 Nov; 116():419-23. PubMed ID: 24184030 [TBL] [Abstract][Full Text] [Related]
17. α-Synuclein modulates fibronectin expression in the trabecular meshwork independent of TGFβ2. Adulla A; Patel U; Ashok A; Katiyar P; Kaulakis M; Kritikos AE; Pillai S; Lee H; Lindner E; Rhee DJ; Singh N Exp Eye Res; 2023 Jan; 226():109351. PubMed ID: 36539052 [TBL] [Abstract][Full Text] [Related]
18. Effects of Salidroside on Trabecular Meshwork Cell Extracellular Matrix Expression and Mouse Intraocular Pressure. Fan Y; Guo L; Wei J; Chen J; Sun H; Guo T Invest Ophthalmol Vis Sci; 2019 May; 60(6):2072-2082. PubMed ID: 31091314 [TBL] [Abstract][Full Text] [Related]
19. Gremlin Induces Ocular Hypertension in Mice Through Smad3-Dependent Signaling. McDowell CM; Hernandez H; Mao W; Clark AF Invest Ophthalmol Vis Sci; 2015 Aug; 56(9):5485-92. PubMed ID: 26284554 [TBL] [Abstract][Full Text] [Related]
20. Knockout of tissue transglutaminase ameliorates TGFβ2-induced ocular hypertension: A novel therapeutic target for glaucoma? Raychaudhuri U; Millar JC; Clark AF Exp Eye Res; 2018 Jun; 171():106-110. PubMed ID: 29535003 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]